Avise Financial Cooperative’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$632K Buy
1,633
+297
+22% +$110K 0.45% 49
2026
Q1
$391K Buy
1,336
+48
+4% +$15.8K 0.32% 64
2025
Q4
$452K Buy
+1,288
New +$435K 0.41% 48

Other funds holding ELV

Avise Financial Cooperative's ELV Position: Q2 2026 in Review

Avise Financial Cooperative increased its Elevance Health (ELV) stake by 22% in Q2 2026, buying an estimated $110K and bringing the position to 1,633 shares worth $632K. The position accounts for 0.45% of the portfolio, ranked #49.

Avise Financial Cooperative first reported a position in ELV in Q4 2025 and has held it in 3 quarters since. 1,596 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Avise Financial Cooperative held 1,633 shares of Elevance Health worth $632K as of Q2 2026.
  • Avise Financial Cooperative bought 297 Elevance Health shares in Q2 2026, an estimated $110K.
  • Elevance Health made up 0.45% of Avise Financial Cooperative's portfolio in Q2 2026, its #49 holding.
  • Avise Financial Cooperative first reported a position in Elevance Health in Q4 2025 and has held it in 3 quarters since.
  • 1,596 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Avise Financial Cooperative's 13F filing for Q2 2026, filed 6 Aug 2026.